Skip to main content

Articles

Page 1 of 47

  1. Fibrin(ogen) amyloid microclots and platelet hyperactivation previously reported as a novel finding in South African patients with the coronavirus 2019 disease (COVID-19) and Long COVID/Post-Acute Sequelae of ...

    Authors: Etheresia Pretorius, Chantelle Venter, Gert Jacobus Laubscher, Maritha J Kotze, Sunday O. Oladejo, Liam R. Watson, Kanshu Rajaratnam, Bruce W. Watson and Douglas B. Kell
    Citation: Cardiovascular Diabetology 2022 21:148
  2. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) improve endothelial dysfunction and reduce cardiovascular events in individuals with type 2 diabetes (T2D). Proprotein convertase subtilisin/kexin 9 (PCSK9i) ...

    Authors: Andrei C. Sposito, Ikaro Breder, Joaquim Barreto, Jessica Breder, Isabella Bonilha, Marcus Lima, Alessandra Oliveira, Vaneza Wolf, Beatriz Luchiari, Helison R. do Carmo, Daniel Munhoz, Daniela Oliveira, Otavio R. Coelho-Filho, Otavio R. Coelho, Jose Roberto Matos-Souza, Filipe A. Moura…
    Citation: Cardiovascular Diabetology 2022 21:147
  3. High glycated-hemoglobin (HbA1c) levels correlated with an elevated risk of adverse cardiovascular outcomes despite renin-angiotensin system (RAS) inhibition in type-2 diabetic (T2DM) patients with reduced eje...

    Authors: Raffaele Marfella, Nunzia D’Onofrio, Gelsomina Mansueto, Vincenzo Grimaldi, Maria Consiglia Trotta, Celestino Sardu, Ferdinando Carlo Sasso, Lucia Scisciola, Cristiano Amarelli, Salvatore Esposito, Michele D’Amico, Paolo Golino, Marisa De Feo, Giuseppe Signoriello, Pasquale Paolisso, Emanuele Gallinoro…
    Citation: Cardiovascular Diabetology 2022 21:146
  4. The Global Registry of Acute Coronary Events (GRACE) score derived from clinical parameters at the time of hospital discharge is a powerful predictor of long-term mortality and reinfarction after acute coronar...

    Authors: Shiqiang Xiong, Qiang Chen, Xu Chen, Jun Hou, Yingzhong Chen, Yu Long, Siqi Yang, Lingyao Qi, Hong Su, Wenchao Huang, Hanxiong Liu, Zhen Zhang and Lin Cai
    Citation: Cardiovascular Diabetology 2022 21:145
  5. Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in patients with type 2 diabetes (T2D). Historical concerns about cardiovascular (CV) risks associated with certain glucose-lowering...

    Authors: Melanie J. Davies, Heinz Drexel, François R. Jornayvaz, Zoltan Pataky, Petar M. Seferović and Christoph Wanner
    Citation: Cardiovascular Diabetology 2022 21:144
  6. The influence of diabetes on the mortality and risk of implantable cardioverter defibrillator (ICD) therapies is still controversial, and a comprehensive assessment is lacking. We performed this systematic rev...

    Authors: Hualong Liu, Jinzhu Hu, Wen Zhuo, Rong Wan and Kui Hong
    Citation: Cardiovascular Diabetology 2022 21:143
  7. Premature coronary artery disease (PCAD) has become more common in recent years and is often associated with poor outcomes. Triglyceride-glucose (TyG) index is a simple and reliable surrogate for insulin resis...

    Authors: Zhenguo Wu, Li Liu, Weiwei Wang, Huiliang Cui, Yerui Zhang, Jiechang Xu, Wencheng Zhang, Tengfei Zheng and Jianmin Yang
    Citation: Cardiovascular Diabetology 2022 21:142
  8. It has been suggested that the baseline triglyceride-glucose (TyG) index, a simple surrogate measure for insulin resistance, is significantly associated with the occurrence of stroke. Nevertheless, the impact ...

    Authors: Zegui Huang, Xiong Ding, Qing Yue, Xianxuan Wang, Zekai Chen, Zefeng Cai, Weijian Li, Zhiwei Cai, Guanzhi Chen, Yulong Lan, Weiqiang Wu, Shouling Wu and Youren Chen
    Citation: Cardiovascular Diabetology 2022 21:141
  9. Stress induced hyperglycemia (SIH) is common among patients with ST-elevation myocardial infarction (STEMI), even in patients without diabetes mellitus. However, evidence regarding its role on the angiographic...

    Authors: Nikolaos Stalikas, Andreas S. Papazoglou, Efstratios Karagiannidis, Eleftherios Panteris, Dimitrios Moysidis, Stylianos Daios, Vasileios Anastasiou, Vasiliki Patsiou, Triantafyllia Koletsa, George Sofidis, Georgios Sianos and George Giannakoulas
    Citation: Cardiovascular Diabetology 2022 21:140
  10. Recent studies have shown that sodium-glucose cotransporter-2 inhibitors (SGLT2i) can achieve significant improvement in blood pressure in people with diabetes. Furthermore, randomized controlled trials (RCTs)...

    Authors: Min Li, Tieci Yi, Fangfang Fan, Lin Qiu, Zhi Wang, Haoyu Weng, Wei Ma, Yan Zhang and Yong Huo
    Citation: Cardiovascular Diabetology 2022 21:139
  11. Ketone monoester β-hydroxybutyrate (KEβHB) ingestion has emerged as an effective method of inducing acute ketosis. Although evidence suggests that KEβHB can offer several therapeutic benefits, whether KEβHB af...

    Authors: Yutong Liu, Sakina H. Bharmal, Wandia Kimita and Maxim S. Petrov
    Citation: Cardiovascular Diabetology 2022 21:138
  12. Several previous studies have indicated that the triglyceride-glucose index (TyG) index is associated with carotid atherosclerosis (CA); however, the evidence of the association is limited and inconsistent, wh...

    Authors: Wenzhen Li, Dajie Chen, Yueqing Tao, Zuxun Lu and Dongming Wang
    Citation: Cardiovascular Diabetology 2022 21:137
  13. The high heterogeneity in the symptoms and severity of COVID-19 makes it challenging to identify high-risk patients early in the disease. Cardiometabolic comorbidities have shown strong associations with COVID...

    Authors: Philip H. Schroeder, Laura N. Brenner, Varinderpal Kaur, Sara J. Cromer, Katrina Armstrong, Regina C. LaRocque, Edward T. Ryan, James B. Meigs, Jose C. Florez, Richelle C. Charles, Josep M. Mercader and Aaron Leong
    Citation: Cardiovascular Diabetology 2022 21:136
  14. Cardiovascular disease remains the leading cause of mortality in individuals with diabetes and improved understanding of its pathophysiology is needed. We investigated the association of a large panel of metab...

    Authors: Luis F. Ferreira-Divino, Tommi Suvitaival, Viktor Rotbain Curovic, Nete Tofte, Kajetan Trošt, Ismo M. Mattila, Simone Theilade, Signe A. Winther, Tine W. Hansen, Marie Frimodt-Møller, Cristina Legido-Quigley and Peter Rossing
    Citation: Cardiovascular Diabetology 2022 21:135
  15. We examined multi-dimensional clinical and laboratory data in participants with normoglycemia, prediabetes, and diabetes to identify characteristics of prediabetes and predictors of progression from prediabete...

    Authors: Ranee Chatterjee, Lydia Coulter Kwee, Neha Pagidipati, Lynne H. Koweek, Priyatham S. Mettu, Francois Haddad, David J. Maron, Fatima Rodriguez, Jessica L. Mega, Adrian Hernandez, Kenneth Mahaffey, Latha Palaniappan and Svati H. Shah
    Citation: Cardiovascular Diabetology 2022 21:134
  16. Evidence for the relationship between glycated hemoglobin (HbA1c) levels and risk of cardiovascular diseases (CVD) in patients with gout remained sparse and limited. This study aims to explore the associations...

    Authors: Likang Li, Gregory Y. H. Lip, Shuai Li, Jonathan D. Adachi, Lehana Thabane and Guowei Li
    Citation: Cardiovascular Diabetology 2022 21:133
  17. Prior studies of the glycemic effect of statins have been inconsistent. Also, most studies have only considered a short duration of statin use; the effect of long-term statin use on fasting glucose (FG) has no...

    Authors: Tanushree Haldar, Akinyemi Oni-Orisan, Thomas J. Hoffmann, Catherine Schaefer, Carlos Iribarren, Ronald M. Krauss, Marisa W. Medina and Neil Risch
    Citation: Cardiovascular Diabetology 2022 21:132
  18. Few studies have examined associations between genetic risk for type 2 diabetes (T2D), lifestyle, clinical risk factors, and cardiovascular disease (CVD). We aimed to investigate the association of and potenti...

    Authors: Jae-Seung Yun, Sang-Hyuk Jung, Manu Shivakumar, Brenda Xiao, Amit V. Khera, Hong-Hee Won and Dokyoon Kim
    Citation: Cardiovascular Diabetology 2022 21:131
  19. Liver pathology (LP) characteristic of non-alcoholic fatty acid disease (NAFLD)/non-alcoholic steatohepatitis (NASH) is a prevalent co-morbidity of type 2 diabetes (T2D). Accumulating evidence indicates that n...

    Authors: Brett E. Phillips, Louise Lantier, Carl Engman, Yesica Garciafigueroa, Aatur Singhi, Massimo Trucco, Christos Mantzoros, David Wasserman and Nick Giannoukakis
    Citation: Cardiovascular Diabetology 2022 21:130
  20. Mannose binding lectin (MBL) has been suggested to be associated with an impaired cardiovascular prognosis in dysglycaemic conditions, but results are still contrasting.

    Authors: Sara Meziani, Giulia Ferrannini, Mette Bjerre, Troels K. Hansen, Viveca Ritsinger, Anna Norhammar, Viveca Gyberg, Per Näsman, Lars Rydén and Linda G. Mellbin
    Citation: Cardiovascular Diabetology 2022 21:129
  21. Triglyceride-glucose (TyG) index as a reliable surrogate of insulin resistance (IR) has been shown to be related to adverse clinical outcomes in patients with acute coronary syndrome, heart failure, ischemic s...

    Authors: Ying Liao, Rongting Zhang, Shanshan Shi, Yukun Zhao, Yibo He, Lihua Liao, Xueqin Lin, Qian Guo, Yani Wang, Liling Chen, Weiguo Li, Shihai Li, Kaihong Chen and Yong Fang
    Citation: Cardiovascular Diabetology 2022 21:128
  22. Raised liver function tests (LFTs) have been correlated with multiple metabolic abnormalities and variably associated with cardiorenal outcomes. We sought to systematically test the relationship between LFT le...

    Authors: Giulia Ferrannini, Norman Rosenthal, Michael K. Hansen and Ele Ferrannini
    Citation: Cardiovascular Diabetology 2022 21:127
  23. Outcome prediction tools for patients with type 2 diabetes mellitus (T2DM) undergoing percutaneous coronary intervention (PCI) are lacking. Here, we developed a machine learning-based metabolite classifier for...

    Authors: Xue-bin Wang, Ning-hua Cui and Xia’nan Liu
    Citation: Cardiovascular Diabetology 2022 21:126
  24. Obesity is strongly associated with the development of cardiovascular disease (CVD). However, the heterogenous nature of obesity in CVD-risk is still poorly understood. We aimed to explore novel CVD biomarkers...

    Authors: Johan Korduner, Hannes Holm, Amra Jujic, Olle Melander, Manan Pareek, John Molvin, Lennart Råstam, Ulf Lindblad, Bledar Daka, Margret Leosdottir, Peter M. Nilsson, Erasmus Bachus, Michael H. Olsen and Martin Magnusson
    Citation: Cardiovascular Diabetology 2022 21:125
  25. The triglyceride-glucose (TyG) index is a new alternative measure for insulin resistance. This meta-analysis was conducted to assess the associations of the TyG index with the risks of cardiovascular diseases ...

    Authors: Xiao Liu, Ziqi Tan, Yuna Huang, Huilei Zhao, Menglu Liu, Peng Yu, Jianyong Ma, Yujie Zhao, Wengen Zhu and Jingfeng Wang
    Citation: Cardiovascular Diabetology 2022 21:124
  26. Insulin resistance (IR), endothelial dysfunction, inflammation, glucose and lipid metabolism disorders, and thrombosis are believed involved in coronary heart disease (CHD) and non-alcoholic fatty liver diseas...

    Authors: Jianqi Zhao, Hongxuan Fan, Ting Wang, Bing Yu, Shaobin Mao, Xun Wang, Wenjing Zhang, Leigang Wang, Yao Zhang, Zhaoyu Ren and Bin Liang
    Citation: Cardiovascular Diabetology 2022 21:123
  27. Diabetes is a metabolic disorder that affects millions of people worldwide. Diabetic heart disease (DHD) comprises coronary artery disease, heart failure, cardiac autonomic neuropathy, peripheral arterial dise...

    Authors: Dhananjie Chandrasekera and Rajesh Katare
    Citation: Cardiovascular Diabetology 2022 21:122
  28. In statins-treated diabetic mellitus (DM) patients, longitudinal coronary CTA (CCTA) evidence is scarce regarding the relationship between coronary Agatston artery calcification scores (CACs) and coronary plaq...

    Authors: Rui Shi, Yue Gao, Li-Ling Shen, Ke Shi, Jin Wang, Li Jiang, Yuan Li and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2022 21:121
  29. Type 2 diabetes mellitus (DM) is a frequent co-morbidity among patients suffering from infective endocarditis (IE). The aim of the study was to evaluate the impact of type 2 DM on the early-, intermediate- and...

    Authors: Alexander Kogan, Anat Wieder-Finesod, Jonathan Frogel, Yael Peled-Potashnik, Eilon Ram, Ehud Raanani and Leonid Sternik
    Citation: Cardiovascular Diabetology 2022 21:120
  30. Atrial fibrillation, the most common cardiac arrhythmia, results in substantial morbidity and mortality related to its increased risks of stroke, heart failure, and impaired cognitive function. The incidence a...

    Authors: Syona S Shetty and Andrew Krumerman
    Citation: Cardiovascular Diabetology 2022 21:119
  31. Although a few meta-analyses were conducted to compare the risk of incident atrial fibrillation (AF) between sodium-glucose cotransporter-2 inhibitor (SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1R...

    Authors: Yi-Hsin Chan, Tze-Fan Chao, Shao-Wei Chen, Hsin-Fu Lee, Pei-Ru Li, Wei-Min Chen, Yung-Hsin Yeh, Chi-Tai Kuo, Lai-Chu See and Gregory Y. H. Lip
    Citation: Cardiovascular Diabetology 2022 21:118
  32. Previous research has linked elevated low-density lipoprotein cholesterol (LDL-C) and remnant cholesterol (RC) with diabetes mellitus (DM). The present study aims to estimate the RC-related DM risk beyond LDL-...

    Authors: Xiangming Hu, Qunzhi Liu, Xingyuan Guo, Weimian Wang, Bingyan Yu, Beijia Liang, Yingling Zhou, Haojian Dong and Jijin Lin
    Citation: Cardiovascular Diabetology 2022 21:117
  33. To determine whether there were racial differences in short-term cardiometabolic responses to once-weekly exenatide (EQW) in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).

    Authors: Timothy M. E. Davis, Anna Giczewska, Yuliya Lokhnygina, Robert J. Mentz, Naveed Sattar and Rury R. Holman
    Citation: Cardiovascular Diabetology 2022 21:116
  34. The residual SYNTAX score (rSS), a quantitative measure of angiographic completeness of revascularization after percutaneous coronary intervention (PCI), and the triglyceride–glucose index (TyG index), a relia...

    Authors: Shiqiang Xiong, Qiang Chen, Zhen Zhang, Yingzhong Chen, Jun Hou, Caiyan Cui, Lianchao Cheng, Hong Su, Yu Long, Siqi Yang, Lingyao Qi, Xu Chen, Hanxiong Liu and Lin Cai
    Citation: Cardiovascular Diabetology 2022 21:115
  35. Admission hyperglycemia is associated with poor prognosis in patients with acute myocardial infarction (AMI), but the effects of baseline diabetes status on this association remain elusive. We aim to investiga...

    Authors: Hanzohra Upur, Jia-Li Li, Xiao-Guang Zou, Yu-Ying Hu, He-Yin Yang, Alimujiang Abudoureyimu, Anwar Abliz, Mamatili Abdukerim and Min Huang
    Citation: Cardiovascular Diabetology 2022 21:114
  36. We evaluated whether measures of glucose dysregulation are associated with subclinical cardiac dysfunction, as assessed by speckle-tracking echocardiography, in an older population.

    Authors: Parveen K. Garg, Mary L. Biggs, Jorge R. Kizer, Sanjiv J. Shah, Bruce Psaty, Mercedes Carnethon, John S. Gottdiener, David Siscovick and Kenneth J. Mukamal
    Citation: Cardiovascular Diabetology 2022 21:112
  37. Compared with enalapril, sacubitril/valsartan lowered HbA1c and reduced new insulin therapy in patients with heart failure with reduced ejection fraction (HFrEF) and diabetes in the PARADIGM-HF trial. We sough...

    Authors: Magnus O. Wijkman, Brian Claggett, Muthiah Vaduganathan, Jonathan W. Cunningham, Rasmus Rørth, Alice Jackson, Milton Packer, Michael Zile, Jean Rouleau, Karl Swedberg, Martin Lefkowitz, Sanjiv J. Shah, Marc A. Pfeffer, John J. V. McMurray and Scott D. Solomon
    Citation: Cardiovascular Diabetology 2022 21:110
  38. Adverse ventricular structure and function is a key pathogenic mechanism of heart failure. Observational studies have shown that both insulin resistance (IR) and glycemic level are associated with adverse vent...

    Authors: Sizhi Ai, Xiaoyu Wang, Shanshan Wang, Yilin Zhao, Shuxun Guo, Guohua Li, Zhigang Chen, Fei Lin, Sheng Guo, Yan Li, Jihui Zhang and Guoan Zhao
    Citation: Cardiovascular Diabetology 2022 21:109
  39. Findings from the T.O.S.CA. Registry recently reported that patients with concomitant chronic heart failure (CHF) and impairment of insulin axis (either insulin resistance—IR or diabetes mellitus—T2D) display ...

    Authors: Andrea Salzano, Roberta D’Assante, Massimo Iacoviello, Vincenzo Triggiani, Giuseppe Rengo, Francesco Cacciatore, Ciro Maiello, Giuseppe Limongelli, Daniele Masarone, Angela Sciacqua, Pasquale Perrone Filardi, Antonio Mancini, Maurizio Volterrani, Olga Vriz, Roberto Castello, Andrea Passantino…
    Citation: Cardiovascular Diabetology 2022 21:108
  40. The Food and Drug Administration has approved Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) inhibitors for the treatment of dyslipidemia. However, evidence of the optimal PCSK9 agents targeting PCSK9 f...

    Authors: Xing Wang, Dingke Wen, Yuqi Chen, Lu Ma and Chao You
    Citation: Cardiovascular Diabetology 2022 21:107
  41. Empagliflozin has been reported to protect endothelial cell function, regardless of diabetes status. However, the role of empagliflozin in microvascular protection during myocardial ischemia reperfusion injury...

    Authors: Rongjun Zou, Wanting Shi, Junxiong Qiu, Na Zhou, Na Du, Hao Zhou, Xinxin Chen and Li Ma
    Citation: Cardiovascular Diabetology 2022 21:106
  42. Recent studies have suggested that triglyceride-glucose (TyG) index is an independent predictor of cardiovascular disease (CVD). However, the impact of long-term visit-to-visit variability in TyG index on the ...

    Authors: Haibin Li, Yingting Zuo, Frank Qian, Shuohua Chen, Xue Tian, Penglian Wang, Xia Li, Xiuhua Guo, Shouling Wu and Anxin Wang
    Citation: Cardiovascular Diabetology 2022 21:105
  43. Type-2 diabetes (T2D), chronic kidney disease, and heart failure (HF) share epidemiological and pathophysiological features. Although their prevalence was described, there is limited contemporary, high-resolut...

    Authors: Meir Schechter, Cheli Melzer Cohen, Ilan Yanuv, Aliza Rozenberg, Gabriel Chodick, Johan Bodegård, Lawrence A. Leiter, Subodh Verma, Hiddo J. Lambers Heerspink, Avraham Karasik and Ofri Mosenzon
    Citation: Cardiovascular Diabetology 2022 21:104
  44. Assessing the spectrum of disease risk associated with hypertriglyceridemia is needed to inform potential benefits from emerging triglyceride lowering treatments. We sought to examine the associations between ...

    Authors: Riyaz S. Patel, Laura Pasea, Handrean Soran, Paul Downie, Richard Jones, Aroon D. Hingorani, Dermot Neely, Spiros Denaxas and Harry Hemingway
    Citation: Cardiovascular Diabetology 2022 21:102
  45. Heart failure (HF) is a growing complication and one of the leading causes of mortality in people living with type 2 diabetes (T2D). Among the possible causes, the excess of red meat and the insufficiency of v...

    Authors: Matthieu Wargny, Mikaël Croyal, Stéphanie Ragot, Elise Gand, David Jacobi, Jean-Noël Trochu, Xavier Prieur, Cédric Le May, Thomas Goronflot, Bertrand Cariou, Pierre-Jean Saulnier and Samy Hadjadj
    Citation: Cardiovascular Diabetology 2022 21:101
  46. Functional mitral regurgitation (FMR) in type 2 diabetes mellitus (T2DM) patients induced by left ventricular (LV) enlargement and mitral valve abnormality may aggravated the impairment in left atrial (LA) com...

    Authors: Yi Zhang, Xue-Ming Li, Meng-Ting Shen, Shan Huang, Yuan Li and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2022 21:100
  47. The association between osteocalcin and mortality has been scantly studied. We aimed to investigate the association between osteocalcin along with its trajectories and mortality based on long-term longitudinal...

    Authors: Yun Shen, Lei Chen, Jian Zhou, Chunfang Wang, Fei Gao, Wei Zhu, Gang Hu, Xiaojing Ma, Han Xia and Yuqian Bao
    Citation: Cardiovascular Diabetology 2022 21:98
  48. Arterial stiffness is a potential biomarker for cardiovascular disease (CVD) risk in patients with type 1 diabetes (T1D). However, its relation with other CV risk evaluation tools in T1D has not been elucidate...

    Authors: Simon Helleputte, Luc Van Bortel, Francis Verbeke, Jos Op ‘t Roodt, Patrick Calders, Bruno Lapauw and Tine De Backer
    Citation: Cardiovascular Diabetology 2022 21:97

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics